US Bancorp’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,559
| Closed | -$71K | – | 4235 |
|
|
2021
Q3 | $71K | Sell |
3,559
-17,311
| -83% | -$345K | ﹤0.01% | 2466 |
|
|
2021
Q2 | $779K | Buy |
20,870
+1,636
| +9% | +$61.1K | ﹤0.01% | 1325 |
|
|
2021
Q1 | $492K | Sell |
19,234
-214
| -1% | -$5.47K | ﹤0.01% | 1503 |
|
|
2020
Q4 | $428K | Buy |
19,448
+2,254
| +13% | +$49.6K | ﹤0.01% | 1522 |
|
|
2020
Q3 | $309K | Buy |
17,194
+13,159
| +326% | +$236K | ﹤0.01% | 1575 |
|
|
2020
Q2 | $102K | Buy |
4,035
+1,060
| +36% | +$26.8K | ﹤0.01% | 2077 |
|
|
2020
Q1 | $55K | Buy |
2,975
+1,775
| +148% | +$32.8K | ﹤0.01% | 2269 |
|
|
2019
Q4 | $27K | Buy |
+1,200
| New | +$27K | ﹤0.01% | 2742 |
|